
Genesis Therapeutics
Developer of a computational platform designed for the discovery of small-molecule drugs. The company leverages a proprietary molecular artificial intelligence technology that drives the discovery and...
Valuation
$0
Share Price
N/A
Total Raised
$327.4M
Last Round
N/A